Dear Pharma Pals,

The revised Schedule M now includes 13 parts that outline Good Manufacturing Practice (GMP) guidelines, ensuring that the specific requirements for pharmaceutical drug manufacturing are met. Notably, the updated rules also introduce five new drug categories that were not addressed in the previous regulations.

In this issue, we explore emerging trends in label packaging, such as digital labeling, e-labeling, smart labels, and custom labels. There is also a growing emphasis on regulatory compliance, eco-friendly materials, and sustainability. Dr. Avinash Talwar highlights the importance of pharmaceutical labeling as a vital part of the industry, where accurately
presenting crucial information on drug products is paramount. At the same time the industry is facing increasing pressure to adopt more environmentally conscious labeling and packaging practices. Artificial intelligence (AI) and machine learning (ML) are reshaping pharmaceutical manufacturing processes.

Additionally, read about the 10th edition of PharmaLytica, organized by Informa Markets in India, which recently concluded at HITEX, Hyderabad. The event provided a dynamic platform for stakeholders to discuss a wide range of topics, including pharma machinery and packaging, lab analytical and cleanroom solutions, and pharmaceutical ingredients

Harjit Singh Dhaul
Publisher & Editor